DR. SUNSHINE MURRAY M.D. NPI 1184818551

NPI Details

DR. Sunshine Murray, M.D. is an urology in Tulsa, OK with 22 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Sunshine Murray, M.D. NPI is 1184818551. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

10901 E 48TH ST
TULSA, OK
ZIP 74146-830
Phone: (918) 749-8765
Fax: (918) 392-2155

The NPI 1184818551 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, heparin sodium, per 1000 units (HCPCS:J1644)
• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Automated urinalysis test (HCPCS:81003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of temporary bladder tube (HCPCS:51701)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Simple bladder irrigation and/or instillation (HCPCS:51700)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Insertion of device into abdomen with pressure and urine flow rate study (HCPCS:51797)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings (HCPCS:51784)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies (HCPCS:51729)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Simple change of bladder tube (HCPCS:51705)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Injection, cefazolin sodium, 500 mg (HCPCS:J0690)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming (HCPCS:95972)
• Insertion of lower leg neurostimulator electrode (HCPCS:64566)
• Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies (HCPCS:L8606)
• Pessary, non rubber, any type (HCPCS:A4562)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Fitting and insertion of vaginal support device (HCPCS:57160)
• Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes (HCPCS:99152)
• Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes (HCPCS:99153)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Injection, fentanyl citrate, 0.1 mg (HCPCS:J3010)
• Injection, promethazine hcl, up to 50 mg (HCPCS:J2550)
• Surgical repair of vaginal defect using an endoscope (HCPCS:57425)
• Injection of implant material beneath lining of bladder and/or urethra using an endoscope (HCPCS:51715)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Blood creatinine level (HCPCS:82565)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Creation of sling around urethra in female to control leakage (HCPCS:57288)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Injection, tobramycin sulfate, up to 80 mg (HCPCS:J3260)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)

The enumeration date for this NPI number is 8/29/2007 and was last updated on 7/5/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.